FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula VIla:
where: R84 is selected from a group consisting of hydrogen, C1-6alkoxy, and -Cl; R92, R94, R95 and R96 are independently selected from a group consisting of hydrogen, halogen and fluoro-substituted C1-6alkyl; R99 is selected from a group consisting of C1-6alkyl, optionally substituted phenyl, thiophene and -NR79R80, where the phenyl substitutes are selected from halogen and fluoro-substituted C1-6alkyl; and R79 and R80 are independently hydrogen or C1-6alkyl, or R79 and R80 are combined with a nitrogen atom with which they are bonded to form a 5-7-member heterocycloalkyl in which 1-3 carbon atoms are substituted with O, S or N heteroatoms.
EFFECT: said compounds are active with respect to protein kinase.
25 cl, 2 tbl, 59 ex
Title | Year | Author | Number |
---|---|---|---|
PYROLLO [2,3-B]PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | 2012 |
|
RU2629999C2 |
COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR USE OF SAID COMPOUNDS AND METHODS | 2008 |
|
RU2487121C2 |
COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USE THEREOF | 2007 |
|
RU2452738C2 |
PYRROLO[2,3-B]PYRIDINE DERIVATIVE AS PROTEIN KINASE INHIBITORS | 2006 |
|
RU2418800C2 |
COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR THEIR USE | 2013 |
|
RU2666146C2 |
KINASES MODULATION AND INDICATIONS FOR ITS USE | 2012 |
|
RU2631487C2 |
NOVEL COMPOUNDS AND FASN INHIBITION COMPOSITIONS | 2014 |
|
RU2737434C2 |
INDOLIN-2-ONE OR PYRROLO-PYRIDIN/PYRIMIDIN-2-ONE DERIVATIVES | 2014 |
|
RU2666532C2 |
DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE | 2014 |
|
RU2662832C2 |
PHTHALAZINE KETONE DERIVATIVE, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION | 2011 |
|
RU2564527C2 |
Authors
Dates
2015-10-20—Published
2006-06-21—Filed